To explore the role of nanoimmunobiotechnomedicine in depression management, emphasizing how nanotechnology and immunobiology offer innovative approaches to understanding and treating depression. The integration of nanotechnology and immunobiology enhances bioavailability and specificity in targeting depressive disorders at the molecular level.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Nov 01, 2025 |
| Journal | Advanced pharmaceutical bulletin |
| Authors | Anurogo Dito, Ratnasari Ririn Tri, Irmania Novi, Maulana Muhammad Sobri, Audah Kholis Abdurachim |
| DOI | 10.34172/apb.025.42757 |
| Source | PubMed |